Run-Lin Gao M.d.

Principal Investigator of Neucardin™’s Phase II & III Clinical Trial at Zensun

Dr. Gao is the principal investigator of all the clinical trials for NeucardinTM that have been conducted in China. He worked as the head of the Cardiovascular Disease Institute of the Chinese Academy of Medical Sciences and Fuwai Hospital, and is now taking responsibility as the Vice Chairman of the Chinese Doctor Association, Standing Director of the Chinese Medical Association, FACC, and Chief Editor of the Chinese Medical Journal. Professor Gao was the first to perform emergency percutaneous transluminal coronary angioplasty for acute myocardial infarction and the first to report the use of coronary stenting and drug-eluting stents in China. He has received seven academic awards, and has more than 490 original publications.

Org chart

Peers

Timeline

  • Principal Investigator of Neucardin™’s Phase II & III Clinical Trial

    Current role

View in org chart